Stelten BML - Search Results

1

Movement disorders in cerebrotendinous xanthomatosis.

Stelten BML, van de Warrenburg BPC, Wevers RA, Verrips A. Stelten BML, et al. Parkinsonism Relat Disord. 2019 Jan;58:12-16. doi: 10.1016/j.parkreldis.2018.07.006. Epub 2018 Jul 19. Parkinsonism Relat Disord. 2019. PMID: 30054180 Review.

2

Cerebellar Disease Mimicking Cerebrotendinous Xanthomatosis: Langerhans Cell Histiocytosis.

Stelten BML, van der Knaap MS, Wevers RA, Verrips A. Stelten BML, et al. Pediatr Neurol. 2017 Aug;73:98-100. doi: 10.1016/j.pediatrneurol.2017.04.007. Epub 2017 Apr 18. Pediatr Neurol. 2017. PMID: 28554492

3

Autism spectrum disorder: an early and frequent feature in cerebrotendinous xanthomatosis.

Stelten BML, Bonnot O, Huidekoper HH, van Spronsen FJ, van Hasselt PM, Kluijtmans LAJ, Wevers RA, Verrips A. Stelten BML, et al. J Inherit Metab Dis. 2018 Jul;41(4):641-646. doi: 10.1007/s10545-017-0086-7. Epub 2017 Sep 11. J Inherit Metab Dis. 2018. PMID: 28894950

4

The safety and effectiveness of chenodeoxycholic acid treatment in patients with cerebrotendinous xanthomatosis: two retrospective cohort studies.

Verrips A, Dotti MT, Mignarri A, Stelten BML, Verma S, Federico A. Verrips A, et al. Among authors: stelten bml. Neurol Sci. 2020 Apr;41(4):943-949. doi: 10.1007/s10072-019-04169-8. Epub 2019 Dec 20. Neurol Sci. 2020. PMID: 31863326 Free PMC article.

5

Long-term treatment effect in cerebrotendinous xanthomatosis depends on age at treatment start.

Stelten BML, Huidekoper HH, van de Warrenburg BPC, Brilstra EH, Hollak CEM, Haak HR, Kluijtmans LAJ, Wevers RA, Verrips A. Stelten BML, et al. Neurology. 2019 Jan 8;92(2):e83-e95. doi: 10.1212/WNL.0000000000006731. Epub 2018 Dec 7. Neurology. 2019. PMID: 30530799

6

Cerebrotendinous xanthomatosis-associated diarrhea and response to chenodeoxycholic acid treatment.

Brass EP, Stelten BML, Verrips A. Brass EP, et al. Among authors: stelten bml. JIMD Rep. 2020 Aug 30;56(1):105-111. doi: 10.1002/jmd2.12163. eCollection 2020 Nov. JIMD Rep. 2020. PMID: 33204601 Free PMC article.

7

Long-term MRI Findings in Patients With Cerebrotendinous Xanthomatosis Treated With Chenodeoxycholic Acid.

Stelten BML, Lycklama À Nijeholt GJ, Hendriks E, Kluijtmans LAJ, Wevers RA, Verrips A. Stelten BML, et al. Neurology. 2022 Sep 27;99(13):559-566. doi: 10.1212/WNL.0000000000201112. Epub 2022 Aug 2. Neurology. 2022. PMID: 35918173

8

Cerebrotendinous xanthomatosis without neurological involvement.

Stelten BML, Raal FJ, Marais AD, Riksen NP, Roeters van Lennep JE, Duell PB, van der Graaf M, Kluijtmans LAJ, Wevers RA, Verrips A. Stelten BML, et al. J Intern Med. 2021 Nov;290(5):1039-1047. doi: 10.1111/joim.13277. Epub 2021 Apr 8. J Intern Med. 2021. PMID: 33830582 Free article.

9

Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi study.

Stelten BML, Dotti MT, Verrips A, Elibol B, Falik-Zaccai TC, Hanman K, Mignarri A, Sithole B, Steiner RD, Verma S, Yahalom G, Zubarioglu T, Mochel F, Federico A. Stelten BML, et al. Orphanet J Rare Dis. 2021 Aug 6;16(1):353. doi: 10.1186/s13023-021-01980-5. Orphanet J Rare Dis. 2021. PMID: 34362411 Free PMC article.

10

Improving neurophysiological biomarkers for functional myoclonic movements.

Beudel M, Zutt R, Meppelink AM, Little S, Elting JW, Stelten BML, Edwards M, Tijssen MAJ. Beudel M, et al. Among authors: stelten bml. Parkinsonism Relat Disord. 2018 Jun;51:3-8. doi: 10.1016/j.parkreldis.2018.03.029. Epub 2018 Apr 6. Parkinsonism Relat Disord. 2018. PMID: 29653908 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters